Today's Change
+0.85%
AI Sentiment
59%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with neutral sentiment across 16 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $REVBW | Revelation Biosciences Inc - Warrants(10/01/2027) | +0.00% |
| $HUMAW | Humacyte Inc - Warrants (27/08/2026) | +5.13% |
| $ERNAW | Ernexa Therapeutics Inc Warrants | +63.87% |
| $CINGW | Cingulate Inc - Warrants (03/12/2026) | -10.38% |
| $BIVIW | BioVie Inc Warrant | +9.38% |
| $CDIOW | Cardio Diagnostics Holdings Inc - Warrants (01/12/2026) | -11.72% |
| $BCTXL | BriaCell Therapeutics Corp Warrants | +7.53% |
| $GRMLW | Greenland Mines Ltd - Warrants(21/06/2029) | +11.00% |
| $CITR | General Enterprise Ventures Inc | +3.17% |
| $SRZNW | Surrozen Inc - Warrants (01/08/2026) | +5.00% |
| $ORGNW | Origin Materials Inc - Warrants (23/06/2026) | -18.18% |
| $ASBPW | Aspire Biopharma Holdings Inc - Warrants (18/02/2030) | +7.88% |
| $SEE | Sealed Air Corp. | +0.00% |
| $KTTAW | Pasithea Therapeutics Corp - Warrants (11/08/2026) | -1.23% |
| $AIMDW | Ainos Inc - Warrants (29/07/2027) | -24.11% |
Materials News
805 articlesGlobeNewswire Inc.41d ago
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewswire Inc.41d ago
Bronstein, Gewirtz & Grossman LLC Urges Coty Inc. Investors to Act: Class Action Filed Alleging Investor Harm
The Motley Fool41d ago
Here's What to Expect for Gold and Silver Mining Stocks as the Iran Conflict Continues
GlobeNewswire Inc.41d ago
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
GlobeNewswire Inc.41d ago
ROSEN, A TOP-RANKED LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO
GlobeNewswire Inc.41d ago
ROSEN, A TRUSTED AND LEADING INVESTOR RIGHTS FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE
GlobeNewswire Inc.41d ago
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
GlobeNewswire Inc.41d ago
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
GlobeNewswire Inc.41d ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
GlobeNewswire Inc.41d ago
Alumis’ Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis
The Motley Fool42d ago
The Chief Commercial Officer of Liquidia (LQDA) Sold 80,000 Shares for $2.8M
Market Sentiment
Neutral
59% Sentiment Score
Sector Stats
Total Stocks198
News Today16
Avg Volume1.3M
AI SentimentNeutral